Old Web
English
Sign In
Acemap
>
authorDetail
>
Gabrielle Boyd
Gabrielle Boyd
Charles River Laboratories
Medicine
Osteoporosis
Myocardial infarction
Pharmacology
Clinical trial
2
Papers
16
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Automatic Quantification of Atherosclerosis in Contrast-Enhanced MicroCT Scans of Mouse Aortas Ex Vivo.
2021
International Journal of Biomedical Imaging
Vincent A. Stadelmann
Gabrielle Boyd
Martin Guillot
Jean-Guy Bienvenu
Charles Glaus
Aurore Varela
Show All
Source
Cite
Save
Citations (0)
Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture.
2020
Regulatory Toxicology and Pharmacology
James R. Turk
Aimée M. Deaton
Jun Yin
Marina Stolina
Melanie Felx
Gabrielle Boyd
Jean-Guy Bienvenu
Aurore Varela
Martin Guillot
Gill Holdsworth
Alison Wolfreys
Denise Dwyer
Sheetal V. Kumar
Emily M. de Koning
Yusheng Qu
Michael Engwall
Kathrin Locher
Lucas D. Ward
Charles Glaus
Yudong D. He
Rogely W. Boyce
Show All
Source
Cite
Save
Citations (16)
1